MetLife Investment Management’s Dynavax Technologies DVAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-54,723
| Closed | -$842K | – | 2789 |
|
|
2025
Q4 | $842K | Sell |
54,723
-3,186
| -6% | -$35.1K | ﹤0.01% | 1526 |
|
|
2025
Q3 | $575K | Sell |
57,909
-5,087
| -8% | -$52.9K | ﹤0.01% | 1736 |
|
|
2025
Q2 | $625K | Sell |
62,996
-16,599
| -21% | -$175K | ﹤0.01% | 1577 |
|
|
2025
Q1 | $1.03M | Sell |
79,595
-1,288
| -2% | -$17K | 0.01% | 1348 |
|
|
2024
Q4 | $1.03M | Buy |
80,883
+4,106
| +5% | +$49.7K | 0.01% | 1394 |
|
|
2024
Q3 | $855K | Hold |
76,777
| – | – | ﹤0.01% | 1480 |
|
|
2024
Q2 | $862K | Buy |
76,777
+8,419
| +12% | +$98K | 0.01% | 1426 |
|
|
2024
Q1 | $848K | Hold |
68,358
| – | – | 0.01% | 1393 |
|
|
2023
Q4 | $956K | Hold |
68,358
| – | – | 0.01% | 1318 |
|
|
2023
Q3 | $1.01M | Hold |
68,358
| – | – | 0.01% | 1223 |
|
|
2023
Q2 | $883K | Buy |
68,358
+6,128
| +10% | +$69.8K | 0.01% | 1339 |
|
|
2023
Q1 | $610K | Hold |
62,230
| – | – | ﹤0.01% | 1509 |
|
|
2022
Q4 | $662K | Hold |
62,230
| – | – | 0.01% | 1464 |
|
|
2022
Q3 | $650K | Buy |
62,230
+1,354
| +2% | +$17.6K | 0.01% | 1446 |
|
|
2022
Q2 | $766K | Buy |
60,876
+3,333
| +6% | +$35.4K | 0.01% | 1364 |
|
|
2022
Q1 | $624K | Buy |
57,543
+20,984
| +57% | +$255K | ﹤0.01% | 1641 |
|
|
2021
Q4 | $514K | Hold |
36,559
| – | – | ﹤0.01% | 1493 |
|
|
2021
Q3 | $702K | Sell |
36,559
-5,687
| -13% | -$75.5K | 0.01% | 1329 |
|
|
2021
Q2 | $416K | Hold |
42,246
| – | – | ﹤0.01% | 1679 |
|
|
2021
Q1 | $415K | Sell |
42,246
-4,817
| -10% | -$39.7K | ﹤0.01% | 1636 |
|
|
2020
Q4 | $209K | Buy |
47,063
+5,611
| +14% | +$25.4K | ﹤0.01% | 1958 |
|
|
2020
Q3 | $179K | Hold |
41,452
| – | – | ﹤0.01% | 1923 |
|
|
2020
Q2 | $368K | Hold |
41,452
| – | – | ﹤0.01% | 1544 |
|
|
2020
Q1 | $146K | Hold |
41,452
| – | – | ﹤0.01% | 1865 |
|
|
2019
Q4 | $237K | Hold |
41,452
| – | – | ﹤0.01% | 1887 |
|
|
2019
Q3 | $148K | Buy |
41,452
+12,762
| +44% | +$49.5K | ﹤0.01% | 2108 |
|
|
2019
Q2 | $114K | Hold |
28,690
| – | – | ﹤0.01% | 2336 |
|
|
2019
Q1 | $210K | Hold |
28,690
| – | – | ﹤0.01% | 1958 |
|
|
2018
Q4 | $263K | Hold |
28,690
| – | – | ﹤0.01% | 1763 |
|
|
2018
Q3 | $356K | Hold |
28,690
| – | – | ﹤0.01% | 1751 |
|
|
2018
Q2 | $438K | Hold |
28,690
| – | – | 0.01% | 1479 |
|
|
2018
Q1 | $569K | Hold |
28,690
| – | – | 0.01% | 1295 |
|
|
2017
Q4 | $537K | Buy |
+28,690
| New | +$576K | 0.01% | 1360 |
|
Other funds holding DVAX
MetLife Investment Management's DVAX Position: Q1 2026 in Review
MetLife Investment Management sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 54,723 shares — an estimated $842K sold.
MetLife Investment Management first reported a position in DVAX in Q4 2017 and held it in 33 quarters. The position peaked at $1.03M in Q4 2024. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.
- MetLife Investment Management reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
- MetLife Investment Management sold 54,723 Dynavax Technologies shares in Q1 2026, an estimated $842K.
- MetLife Investment Management first reported a position in Dynavax Technologies in Q4 2017 and held it in 33 quarters.
- MetLife Investment Management's Dynavax Technologies position peaked at $1.03M in Q4 2024.
- 1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.
Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.